Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical compositions for the treatment of Helicobacter pylori

Pharmaceutical compositions for the treatment of Helicobacter pylori

US Patent 10238606 · Granted Mar 26, 2019

Estimated economic value: $2,722,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Serine protease inhibitor for treating coronavirus infection2025
Therapy for inhibition of single-stranded RNA virus replication2025
Therapy for inhibition of single-stranded RNA virus replication2025
Biomarkers of coronavirus pneumonia2024
Pharmaceutical compositions comprising lonafarnib and ritonavir2024
All-in-one fixed-dose combination for treating Helicobacter pylori infection2024
All-in-one fixed-dose combination for treating Helicobacter pylori infection2024
All-in-one fixed-dose combination for treating Helicobacter pylori infection2024
All-in-one fixed-dose combination for treating Helicobacter pylori infection2024
Serine protease inhibitor for treating coronavirus infection2024
Method for eradicating Helicobacter pylori infection in patients regardless of b2024
Inhibitor of sphingosine kinase 2 for treating Ebola2023